Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Feb 21, 2022
Open Peer Review Period: Feb 21, 2022 - Apr 18, 2022
Date Accepted: May 29, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium

Scheenstra B, Bruninx A, van Daalen F, Stahl N, Latuapon E, Imkamp M, Ippel L, Duijsings-Mahangi S, Smits D, Townend D, Bermejo I, Dekker A, Hochstenbach L, Spreeuwenberg M, Maessen J, van 't Hof A, Kietselaer B

Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium

JMIR Cardio 2022;6(2):e37437

DOI: 10.2196/37437

PMID: 36251353

PMCID: 9623459

Digital health to reduce the burden of atherosclerotic cardiovascular disease. Solutions proposed by the CARRIER consortium

  • Bart Scheenstra; 
  • Anke Bruninx; 
  • Florian van Daalen; 
  • Nina Stahl; 
  • Elizabeth Latuapon; 
  • Maike Imkamp; 
  • Lianne Ippel; 
  • Sulaika Duijsings-Mahangi; 
  • Djura Smits; 
  • David Townend; 
  • Inigo Bermejo; 
  • Andre Dekker; 
  • Laura Hochstenbach; 
  • Marieke Spreeuwenberg; 
  • Jos Maessen; 
  • Arnoud van 't Hof; 
  • Bas Kietselaer

ABSTRACT

Digital health is a promising tool to support people with an elevated risk for atherosclerotic cardiovascular disease (ASCVD) and patients with established disease to improve cardiovascular outcomes. Many digital health initiatives have been developed and employed. However, barriers for their large-scale implementation have remained. This article focuses on these barriers and presents solutions as proposed by the Dutch CARRIER consortium (Coronary ARtery disease: Risk estimations and Interventions for prevention and EaRly detection). We will focus in four chapters on: (i) the development process of an eHealth solution, which will include design thinking and co-creation with relevant stakeholders; (ii) the modeling approach for two clinical prediction models (CPMs) to identify people at risk to develop ASCVD and to inform on lifestyle interventions; (iii) description of a federated data infrastructure to train the CPM and to provide the eHealth solution with relevant data; and (iv) discussion of an ethical and legal framework for responsible data handling in healthcare. The Dutch CARRIER consortium consists of a collaboration between experts in the fields of eHealth development, ASCVD, public health, big-data, and ethics and law. The consortium focuses on the reduction of the burden of ASCVD. We believe the future of healthcare is data-driven and supported by digital health. Therefore, we hope that our research will not only facilitate CARRIER but may also facilitate other future healthcare initiatives.


 Citation

Please cite as:

Scheenstra B, Bruninx A, van Daalen F, Stahl N, Latuapon E, Imkamp M, Ippel L, Duijsings-Mahangi S, Smits D, Townend D, Bermejo I, Dekker A, Hochstenbach L, Spreeuwenberg M, Maessen J, van 't Hof A, Kietselaer B

Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium

JMIR Cardio 2022;6(2):e37437

DOI: 10.2196/37437

PMID: 36251353

PMCID: 9623459

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.